ASCO GI 2019: Genetic Variants in the Lipopolysaccharide Receptor Complex, as well as TLR4 Expression Levels, Prove Predictive in Metastatic Colorectal Cancer
Data from the FIRE-3 phase III trial point to the predictive power of the genetic variants.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.